Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Lock Hansen

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
JAMA|February 25, 2015
Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarctionAnne-Marie Schjerning Olsen, Gunnar H Gislason, Patricia McGettigan, et al.
American Heart Journal|October 19, 2021
Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic eventsPeter Vibe Rasmussen, Paul Blanche, Frederik Dalgaard, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 4, 2024
Disparities in the access to atrial fibrillation ablation in Denmark: who gets ablated, who neglected?Christopher R Zörner, Jacob Tønnesen, Lise Da Riis-Vestergaard, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 17, 2012
The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide studyMartin Huth Ruwald, Morten Lock Hansen, Morten Lamberts, et al.
Heart Rhythm|December 3, 2019
Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational studyPeter Vibe Rasmussen, Frederik Dalgaard, Gunnar Hilmar Gislason, et al.
Heart, Lung & Circulation|December 13, 2022
Impact of Nationwide COVID-19 Lockdowns on the Implantation Rate of Cardiac Implantable Electronic DevicesHannah K Wood-Kurland, Matthew Phelps, Jens Jakob Thune, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide studyAnne-Marie Schjerning Olsen, Emil L Fosbøl, Jannik Pallisgaard, et al.
Clinical Cardiology|March 2, 2013
Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncopeMartin Huth Ruwald, Anne-Christine Ruwald, Christian Jons, et al.
Journal of the American College of Cardiology|May 6, 2014
Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort studyMorten Lamberts, Gregory Y H Lip, Martin H Ruwald, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 12, 2017
Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort studyCengiz Özcan, Jakob Raunsø, Morten Lamberts, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
JAMA|February 25, 2015
Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarctionAnne-Marie Schjerning Olsen, Gunnar H Gislason, Patricia McGettigan, et al.
American Heart Journal|October 19, 2021
Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic eventsPeter Vibe Rasmussen, Paul Blanche, Frederik Dalgaard, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 4, 2024
Disparities in the access to atrial fibrillation ablation in Denmark: who gets ablated, who neglected?Christopher R Zörner, Jacob Tønnesen, Lise Da Riis-Vestergaard, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 17, 2012
The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide studyMartin Huth Ruwald, Morten Lock Hansen, Morten Lamberts, et al.
Heart Rhythm|December 3, 2019
Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational studyPeter Vibe Rasmussen, Frederik Dalgaard, Gunnar Hilmar Gislason, et al.
Heart, Lung & Circulation|December 13, 2022
Impact of Nationwide COVID-19 Lockdowns on the Implantation Rate of Cardiac Implantable Electronic DevicesHannah K Wood-Kurland, Matthew Phelps, Jens Jakob Thune, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide studyAnne-Marie Schjerning Olsen, Emil L Fosbøl, Jannik Pallisgaard, et al.
Clinical Cardiology|March 2, 2013
Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncopeMartin Huth Ruwald, Anne-Christine Ruwald, Christian Jons, et al.
Journal of the American College of Cardiology|May 6, 2014
Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort studyMorten Lamberts, Gregory Y H Lip, Martin H Ruwald, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 12, 2017
Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort studyCengiz Özcan, Jakob Raunsø, Morten Lamberts, et al.
Pageof 14